基于网络药理学与分子对接讨论肾炎方对肾小球肾炎的作用机制
Discussion on the Mechanism of Shenyan Formula in Treating Glomerulonephritis Based on Network Pharmacology and Molecular Docking
DOI: 10.12677/jcpm.2026.51087, PDF,   
作者: 郑长和, 胥国建, 陈 伟*:盐城亭湖区人民医院,江苏 盐城;吴 亮*:江苏大学医学院,江苏 镇江
关键词: 肾炎方肾小球肾炎网络药理学分子对接Nephritis Formula Glomerulonephritis Network Pharmacology Molecular Docking
摘要: 目的:运用网络药理学与分子对接,研究肾炎方对早期肾小球肾炎(GN)的潜在作用机制。方法:在TCMSP数据库中提取五味药材活性成分,通过uniprot和SwissTargetPrediction数据库预测药物活性成分靶点,DrugBank、GeneCards、OMIM和TTD数据库收集GN疾病靶点,药物与疾病靶点取交集;利用STRING软件构建PPI网络,CytoNCA插件筛选核心靶点,Cytoscape软件进行“药物–活性成分–交集靶点–疾病”网络拓扑分析;R语言对交集靶点做GO和KEGG富集分析;AutoDock Vina软件做分子对接,PyMOL软件将结合模式可视化。结果:筛选到186个活性成分,预测到358个成分靶点,并与1157个疾病靶点取交集得到118个交集靶点;网络拓扑锁定IL6、TNF、STAT3、JUN等9个核心靶点以及排名前十位的核心成分;富集指向AGE-RAGE、TNF、IL-17等炎症信号。对接显示二氢丹参酮I对SRC亲和力最高(−9.9 kcal/mol),槲皮素、山奈酚、木犀草素均以氢键锚定SRC,而二氢丹参酮I-TP53靠疏水接触稳定。讨论:肾炎方可能通过调控SRC/STAT3等核心靶点干预GN早期炎症反应,为后续实验验证提供方向。
Abstract: Objective: To investigate the potential mechanism of Shenyan Formula in the treatment of early glomerulonephritis (GN) using network pharmacology and molecular docking. Method: Active components of five medicinal materials were extracted from the TCMSP database. The drug active component targets were predicted through the uniprot and SwissTargetPrediction databases. The GN disease targets were collected from the DrugBank, GeneCards, OMIM and TTD databases, and the intersection of drug and disease targets was taken. The STRING software was used to construct the PPI network, and the CytoNCA plugin was used to screen the core targets. The “drug-active component-intersection target-disease” network topology analysis was performed using Cytoscape software. The R language was used to perform GO and KEGG enrichment analysis on the intersection targets. Molecular docking was performed using AutoDock Vina software, and the binding mode was visualized using PyMOL software. Results: 186 active components were screened, and 358 component targets were predicted. The intersection of these with 1157 disease targets yielded 118 intersection targets. Network topology identified 9 core targets including IL6, TNF, STAT3, and JUN, as well as the top ten core components. Enrichment analysis pointed to inflammatory signaling pathways, such as AGE-RAGE, TNF, and IL-17. Docking studies revealed that dihydrotanshinone I exhibited the highest affinity for SRC (−9.9 kcal/mol), while quercetin, kaempferol, and luteolin were anchored to SRC via hydrogen bonds, and dihydrotanshinone I-TP53 was stabilized by hydrophobic interactions. Discussion: The Nephritis Formula may intervene in the early inflammatory response of GN by regulating core targets such as SRC/STAT3, providing direction for subsequent experimental validation.
文章引用:郑长和, 胥国建, 陈伟, 吴亮. 基于网络药理学与分子对接讨论肾炎方对肾小球肾炎的作用机制[J]. 临床个性化医学, 2026, 5(1): 639-651. https://doi.org/10.12677/jcpm.2026.51087

参考文献

[1] Anders, H.J., Kitching, A.R., Leung, N. and Romagnani, P. (2023) Glomerulonephritis: Immunopathogenesis and Immunotherapy. Nature Reviews Immunology, 23, 453-471. [Google Scholar] [CrossRef] [PubMed]
[2] Gleeson, P.J., Benech, N., Chemouny, J., Metallinou, E., Berthelot, L., da Silva, J., et al. (2024) The Gut Microbiota Posttranslationally Modifies IgA1 in Autoimmune Glomerulonephritis. Science Translational Medicine, 16, eadl6149. [Google Scholar] [CrossRef] [PubMed]
[3] Hu, J., Ke, R., Teixeira, W., et al. (2023) Global, Regional, and National Burden of CKD Due to Glomerulonephritis from 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019. Clinical Journal of the American Society of Nephrology, 18, 60-71. [Google Scholar] [CrossRef] [PubMed]
[4] Dou, L.L., Zhang, X.Y., Liu, D., et al. (2024) Role of Traditional Chinese Medicine for the Treatment of Lupus nephritis: Mechanisms and Applications. Alternative Therapies, Health and Medicine, 30, 154-165.
[5] 高家荣, 施苗苗, 陈浩, 等. 芪藤消浊颗粒介导miR-339-5p对慢性肾小球肾炎大鼠炎症指标的影响[J]. 中国临床药理学与治疗学, 2022, 27(4): 457-465.
[6] 郑舒文, 王柏森, 李志明, 等. 基于网络药理学及分子对接探讨参苓白术散对慢性肾小球肾炎和抑郁症异病同治的作用机制[J]. 中国医科大学学报, 2022, 51(9): 804-809.
[7] 杜世拔, 李国政, 卢微嫒, 等. 健脾固肾方联合常规治疗对脾肾亏虚型早期糖尿病肾病患者的临床疗效[J]. 中成药, 2021, 43(3): 649-653.
[8] 张文杰, 赖星海, 陈佳薇. 山药多糖治疗肥胖糖尿病肾病大鼠的效果观察及对其肾功能和肠道微生态的影响[J]. 中国微生态学杂志, 2021, 33(1): 37-42.
[9] 国家药典委员会. 中华人民共和国药典: 2020 年版. 一部[M]. 北京: 中国医药科技出版社, 2020: 70-71.
[10] Hu, P., Liang, Q.L., Luo, G.A., et al. (2005) Multi-Component HPLC Fingerprinting of Radix Salviae Miltiorrhizae and Its LC-MS-MS Identification. Chemical and Pharmaceutical Bulletin, 53, 677-683. [Google Scholar] [CrossRef] [PubMed]
[11] 许蕊蕊, 周利朋, 刘欣悦, 等. 山药化学成分、药理作用研究进展及质量标志物预测[J]. 中国现代中药, 2025, 27(8): 1564-1574.
[12] Zhang, X., Mei, D., Zhang, L. and Wei, W. (2020) Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases. Inflammation, 44, 423-433. [Google Scholar] [CrossRef] [PubMed]
[13] Huang, Y., Zhao, X., Zhang, Q., Yang, X., Hou, G., Peng, C., et al. (2023) Novel Therapeutic Perspectives for Crescentic Glomerulonephritis through Targeting Parietal Epithelial Cell Activation and Proliferation. Expert Opinion on Therapeutic Targets, 27, 55-69. [Google Scholar] [CrossRef] [PubMed]
[14] Shi, D., Li, Y., Shi, X., Yao, M., Wu, D., Zheng, Y., et al. (2023) Transcriptional Expression of CXCL10 and STAT1 in Lupus Nephritis and the Intervention Effect of Triptolide. Clinical Rheumatology, 42, 539-548. [Google Scholar] [CrossRef] [PubMed]
[15] Cai, Z., Zhang, S., Wu, P., Ren, Q., Wei, P., Hong, M., et al. (2021) A Novel Potential Target of IL-35-Regulated JAK/STAT Signaling Pathway in Lupus Nephritis. Clinical and Translational Medicine, 11, e309. [Google Scholar] [CrossRef] [PubMed]
[16] Tang, Y., Zhang, J., Wang, Z. and Dong, X. (2025) Potential Modulatory Effects of Hesperidin on the JAK/STAT Pathway in Mesangial Proliferative Glomerulonephritis. Chemical Biology & Drug Design, 105, e70032. [Google Scholar] [CrossRef] [PubMed]
[17] Park, J.Y., Yoo, K.D., Bae, E., Kim, K.H., Lee, J.W., Shin, S.J., et al. (2022) Blockade of STAT3 Signaling Alleviates the Progression of Acute Kidney Injury to Chronic Kidney Disease through Antiapoptosis. American Journal of Physiology-Renal Physiology, 322, F553-F572. [Google Scholar] [CrossRef] [PubMed]